
Health data company owned by US health systems, licensing de-identified EHR data and evidence services to researchers.
truveta.comCrawled Oct 16, 2026
Generate regulatory-grade evidence and advance research with real-world healthcare data from 140M+ patients.
The company offers real-world data, analytics, and AI solutions for life science to support therapy adoption and patient care.
Public health solutions using real-world EHR data and analytics to improve safety, population health, and care quality.
Truveta delivers complete, representative, and trusted EHR data with granular device-level insights and minute-level timestamps.
Truveta's EHR data and analytics blog covers healthcare insights and trends.
Using Truveta Data, researchers show the potential for real-world evidence to prompt changes in heart failure treatment decisions and clinical guidelines
The page explains how medical device companies can use real-world data from EHRs to improve device effectiveness and patient outcomes.
Truveta's newsroom features EHR news and company developments.
Truveta's careers page lists open roles.
The page introduces Truveta's leaders and describes its mission to use data to save lives and transform healthcare.
Truveta offers EHR demos and solutions that turn healthcare data into actionable insights.
Turn real-world healthcare data into intelligence and evidence with real-time data from 130M+ patients across US health systems.
Truveta co-founder Terry Myerson is retiring as CEO at the end of September, with co-founders Jay Nanduri and Ryan Ahern set to serve as interim co-CEOs while the board searches for a permanent leader. The Bellevue health-data company pools de-identified records from 30 U.S. health systems, covering more than 140 million patients, and sells data access, analysis and AI tools. Its Truveta Intelligence tool lets researchers query clinical data in plain English.
Sep 2026 · GeekWireNews article
Bellevue-based health data company Truveta launches Truveta Intelligence, an AI-powered tool for researchers and healthcare leaders to query de-identified clinical records using natural language. The tool provides insights on patient populations, treatments, and outcomes from a database covering more than 130 million patients.
Apr 2026 · GeekWireNews article
Truveta introduces Truveta Live Link, a capability that links proprietary first-party datasets into longitudinal clinical and claims data within a single self-governed environment. The environment connects to Truveta Data, which spans more than 130 million patients, enabling prospectively designed real-world research.
Feb 2026 · TruvetaNews article
Dr. Johnathan Lancaster joins Truveta as its new president and chief scientific officer, leading the company's scientific strategy and ecosystem partnerships. The oncologist, cancer genomics expert, and former Regeneron executive explains why he joins the company.
Jan 2026 · TruvetaNews article